Luisa Pozzo | Neuroscience | Best Paper Award

Dr. Luisa Pozzo | Neuroscience | Best Paper Award ย ย ๐Ÿ†

Researcher at IBBA-CNR, Italy

Dr. Luisa Pozzo is a Researcher at the Institute of Agricultural Biology and Biotechnology of the National Research Council (CNR-IBBA) since 2011. She holds a degree in Veterinary Medicine from the University of Turin (2007) and a PhD in Veterinary Sciences (2011) from the same university. Dr. Pozzo also earned a Master’s degree in Food Science from the University of Pisa (2013). Her research focuses on the bio-functional characterization of food products, particularly their role in managing inflammation and oxidative stress in chronic degenerative diseases like diabetes and cardiovascular issues. She has worked internationally in France, Poland, and Spain and currently holds a teaching position at the University of Pisa. With an H-index of 17 and over 663 citations, Dr. Pozzo has made significant contributions to the fields of food science, nutraceuticals, and health research.

Profile

SCOPUS

ORCID

Education ๐ŸŽ“:

Dr. Luisa Pozzo completed her education with a strong focus on veterinary medicine and food science. She graduated in 2007 with a degree in Veterinary Medicine from the University of Turin. Following this, she pursued advanced studies and earned her PhD in Veterinary Sciences (XXIII cycle) from the same university in 2011. Further expanding her expertise, she obtained a 2nd level Master’s degree in “Food Science: quality, safety and human nutrition” from the University of Pisa in 2013. Dr. Pozzo also gained international experience during her PhD training at the Mycotoxicology Unit of the ENVT in France in 2010. This educational background has provided her with a robust foundation in both veterinary science and food-related research, fueling her work in areas like food bio-functionality and chronic disease prevention.

Work Experience ๐Ÿ’ผ:

Dr. Luisa Pozzo has extensive research and teaching experience in the fields of veterinary medicine, food science, and nutrition. Since 2011, she has been a Researcher at the Institute of Agricultural Biology and Biotechnology of the National Research Council (CNR-IBBA), where she focuses on the bio-functional properties of food products in relation to chronic diseases. Her international experience includes a PhD training at the Mycotoxicology Unit at ENVT in France (2010), and research roles as a Host Researcher at the Institute of Animal Reproduction and Food Research in Poland (2015) and IATA CSIC in Spain (2018). Since 2016, Dr. Pozzo has been a university lecturer at the University of Pisa, teaching Applied Nutraceuticals in the Human Nutrition Sciences program. Additionally, she has served as a Section Editor for the Polish Journal of Food and Nutrition Sciences since 2019 and has been a technical-scientific expert for the Italian Ministry of Economic Development. Her work has contributed to advancing the understanding of foodโ€™s role in health, with particular emphasis on antimicrobial and prebiotic effects.

Skills ๐Ÿ”

Dr. Luisa Pozzo possesses a diverse skill set spanning veterinary medicine, food science, and nutrition research. Her expertise includes the bio-functional characterization of food products, with a focus on their role in preventing inflammation and oxidative stress associated with chronic degenerative diseases such as diabetes, cardiovascular diseases, and neurodegenerative disorders. She is skilled in using in vivo models (mice and rats) for testing the interactions between food products and drug metabolism. Additionally, Dr. Pozzo has expertise in antimicrobial and prebiotic effects of food products and bioactive compounds through in vitro testing. Her strong academic background and international research experience have equipped her with advanced skills in scientific communication, project evaluation, and academic mentorship, particularly in the fields of applied nutraceuticals and human nutrition.

Awards and Honors ๐Ÿ†

Dr. Luisa Pozzo has received notable recognition for her contributions to the fields of food science and nutrition. In addition to her academic achievements, she has been acknowledged for her role as a Section Editor for the Polish Journal of Food and Nutrition Sciences (PJFNS) since 2019, where she contributes to advancing nutritional research. Her expertise has also been sought by the Italian Ministry of Economic Development (MiSE), where she has served as a technical-scientific expert for the evaluation of research projects under the Fund for Sustainable Growth. Furthermore, Dr. Pozzoโ€™s dedication to international academic collaboration was recognized through a Staff Mobility for Teaching Assignments (STA) under the Erasmus+ Mobility Program in 2022, further cementing her standing in the global scientific community.

Research Interests:

Dr. Luisa Pozzo’s research interests center around the bio-functional characterization of food products, focusing on their protective roles in combating inflammation and oxidative stress associated with chronic degenerative diseases, including diabetes, cardiovascular diseases, neurodegenerative diseases, and chronic respiratory conditions. She is particularly interested in understanding the interactions between food products, bioactive compounds, and drug metabolism, using in vivo models (mice and rats) to explore these effects. Additionally, Dr. Pozzo investigates the antimicrobial and prebiotic properties of food products, seeking to identify potential health benefits and applications in disease prevention and management. Her research aims to contribute to the development of nutraceutical strategies for improving public health.

๐Ÿ“š Publicationsย 

  • Title: Probing the Alterations in Mice Cecal Content Due to High-Fat Diet
    • Authors: Trouki, C., Campanella, B., Onor, M., Longo, V., Bramanti, E.
    • Journal: Food Chemistry
    • Year: 2024
    • Volume/Issue: 455, 139856
    • Citations: 0
  • Title: Assessment of the Antioxidant and Hypolipidemic Properties of Salicornia europaea for the Prevention of TAFLD in Rats
    • Authors: Souid, A., Giambastiani, L., Castagna, A., Pozzo, L., Vornoli, A.
    • Journal: Antioxidants
    • Year: 2024
    • Volume/Issue: 13(5), 596
    • Citations: 3
  • Title: Characterization and Stability Evaluation of Egyptian Propolis Extract Nano-Capsules and Their Application
    • Authors: Amin, A.A., Mahmoud, K.F., Salama, M.F., Seliem, E.I., Ibrahim, M.A.
    • Journal: Scientific Reports
    • Year: 2023
    • Volume/Issue: 13(1), 16065
    • Citations: 2
  • Title: Chlamydomonas agloeformis from the Ecuadorian Highlands: Nutrients and Bioactive Compounds Profiling and In Vitro Antioxidant Activity
    • Authors: Grande, T., Vornoli, A., Lubrano, V., Echeverria, M.C., Pozzo, L.
    • Journal: Foods
    • Year: 2023
    • Volume/Issue: 12(17), 3147
    • Citations: 4
  • Title: Characterization of Antioxidant and Antimicrobial Activity and Phenolic Compound Profile of Extracts from Seeds of Different Vitis Species
    • Authors: Pozzo, L., Grande, T., Raffaelli, A., Amarowicz, R., Karamaฤ‡, M.
    • Journal: Molecules
    • Year: 2023
    • Volume/Issue: 28(13), 4924
    • Citations: 9
  • Title: In Vitro Characterization of Antioxidant, Antibacterial, and Antimutagenic Activities of the Green Microalga Ettlia pseudoalveolaris
    • Authors: Vornoli, A., Grande, T., Lubrano, V., Pozzo, L., Echeverria, C.
    • Journal: Antioxidants
    • Year: 2023
    • Volume/Issue: 12(6), 1308
    • Citations: 5

Conclusionย 

Given Dr. Luisa Pozzo’s extensive research on the bio-functional roles of food in chronic disease prevention, her strong academic credentials, and her contributions to the field of nutraceuticals, she is a highly suitable candidate for the Research for Best Paper Award. Her research not only enhances our understanding of food’s potential to improve health but also paves the way for innovative solutions to combat chronic diseases.

 

 

Hristina ฤŒoloviฤ‡ | Neuroscience | Robotics Integration Award

Prof. Dr. Hristina ฤŒoloviฤ‡ | Neuroscience | Robotics Integration Award

spec.Physical Medicine and Rehabilitation at University of Nis, Faculty of Medicine, Serbia 2 Physical Medicine and Rehabilitation Clinic, Clinical Center of Nis, Serbia, Serbia๐ŸŽ“

Dr. Hristina ฤŒoloviฤ‡ is an accomplished Physiatrist specializing in physical medicine and rehabilitation, with a particular focus on pediatric rehabilitation and the use of botulinum toxin in treating spasticity in children with cerebral palsy. With a robust academic background, including a PhD in Physical Medicine and Rehabilitation, she has made significant contributions to the field, especially in robotic neurorehabilitation after pediatric stroke. She is actively involved in clinical practice, research, and teaching, and has a record of publications in notable scientific journals.

 

Profileย 

Scopus

Education ๐ŸŽ“:

Dr. Hristina ฤŒoloviฤ‡ completed her undergraduate studies at the Faculty of Medicine, University of Nis, Serbia, in 1992, with a distinguished average grade of 9.06. She pursued specialization in Physical Medicine and Rehabilitation at the same institution, receiving excellent grades (5/5) in 1998. Dr. ฤŒoloviฤ‡ furthered her expertise with a subspecialization in Pediatric Rehabilitation from the Faculty of Medicine, University of Belgrade, in 2007, earning another top grade. She completed her Ph.D. in 2012, focusing on the effects of Botulinum toxin type A in the habilitation of children with cerebral palsy. Her academic foundation and continuing education have provided a solid basis for her leadership in both clinical practice and research. Dr. ฤŒoloviฤ‡’s ongoing commitment to academic development is reflected in her teaching roles, where she lectures on physical medicine, pediatric rehabilitation, and neurorehabilitation at the University of Nis and other institutions.

Work Experience ๐Ÿ’ผ:

Dr. Hristina ฤŒoloviฤ‡ has an extensive career in physical medicine and rehabilitation, spanning over 25 years. She has been a full-time faculty member at the Clinic for Physical Medicine, Rehabilitation, and Prosthetics in Nis, Serbia, since 1995. Starting in 2008, she pioneered the use of botulinum toxin type A in treating children with cerebral palsy, a therapy she has continued to develop and refine. In addition to her clinical practice, Dr. ฤŒoloviฤ‡ has served as a professor at the Faculty of Medicine, University of Nis, specializing in physical medicine and rehabilitation, where she trains future healthcare professionals. She has also been a lecturer in pediatric rehabilitation at the College of Health Sciences in ฤ†upria, Serbia. Dr. ฤŒoloviฤ‡โ€™s career also includes significant involvement in continuing medical education, where she has lectured on topics such as botulinum toxin application and rehabilitation of foot deformities in children.

Awards and Honors๐Ÿ†

Dr. Hristina ฤŒoloviฤ‡ has received numerous awards and honors throughout her distinguished career. She has been recognized for her excellence in both clinical practice and research in the field of physical medicine and rehabilitation. Her contributions to the treatment of children with cerebral palsy using botulinum toxin type A have been particularly noteworthy. In addition to her clinical work, she has earned accolades for her leadership in education and continuous medical training. Dr. ฤŒoloviฤ‡โ€™s research and teaching have been instrumental in advancing pediatric rehabilitation in Serbia and beyond. She has been honored by various medical institutions, including the Serbian Medical Society and the Serbian Medical Chamber. Her role as an invited speaker and lecturer at numerous national and international conferences further highlights her esteemed standing within the medical community. Dr. ฤŒoloviฤ‡’s continued dedication to improving healthcare outcomes, particularly for children with physical disabilities, makes her a respected figure in the field.

Research Focus ๐Ÿ”ฌ:

Dr. Hristina ฤŒoloviฤ‡โ€™s research focuses primarily on pediatric rehabilitation, with a particular emphasis on cerebral palsy and musculoskeletal disorders in children. Her pioneering work on the use of botulinum toxin type A for managing spasticity in children with cerebral palsy has had a significant impact on the field, improving functional outcomes for these children. She is also interested in exploring rehabilitation strategies for other pediatric conditions, such as congenital foot deformities and hip dysplasia. Dr. ฤŒoloviฤ‡โ€™s work involves both clinical applications and functional assessments, aiming to enhance the overall quality of life for children with physical disabilities. Her research contributions include studies on motor activity in premature infants and the effects of rehabilitation interventions on neurological outcomes. Through her research, Dr. ฤŒoloviฤ‡ seeks to bridge the gap between innovative treatments and their practical applications in improving the health and mobility of pediatric patients, particularly those with spasticity and developmental disabilities.

๐Ÿ“š Publications

    • A Review of Current Perspectives on Motoric Insufficiency Rehabilitation following Pediatric Stroke
      Authors: ฤŒoloviฤ‡, H., Zlatanoviฤ‡, D., Zivkoviฤ‡, V., Jovanoviฤ‡, K., Nikoliฤ‡, D.
      Citations: 0
      Year: 2024
    • Can pre-treatment dysfunctional voiding and incontinence scoring system score predict treatment outcome in children with dysfunctional voiding โ€“ a randomized trial
      Authors: ลฝivkoviฤ‡, V.D., ฤŒoloviฤ‡, H., Zlatanoviฤ‡, D., Vlajkoviฤ‡, M.
      Citations: 0
      Year: 2023
    • The importance of assessing general motor activity in premature infants for predicting neurological outcomes
      Authors: Zlatanoviฤ‡, D., ฤŒoloviฤ‡, H., ลฝivkoviฤ‡, V., Vuฤiฤ‡, J., Toลกiฤ‡, T.
      Citations: 1
      Year: 2022
    • Factors associated with poor self-reported function and quality of life in patients with end-stage knee or hip osteoarthritis immediately prior to total joint arthroplasty
      Authors: Kociฤ‡, M., Milenkoviฤ‡, M., Nikoliฤ‡, D., ฤŒoloviฤ‡, H., Stojanoviฤ‡, Z.
      Citations: 4
      Year: 2021
    • Endometrial immunocompetent cells in proliferative and secretory phase of normal menstrual cycle
      Authors: Janoลกevic, D.R., Janoลกevic, D.R., Trandafiloviฤ‡, M., Dinic, S.P.-T., Dinic, S.P.-T.
      Citations: 12
      Year: 2020
    • Upper limb robotic neurorehabilitation after pediatric stroke
      Authors: ฤŒoloviฤ‡, H., Dimitrijeviฤ‡, L., ฤuriฤ‡, V., Jankoviฤ‡, S.
      Citations: 3
      Year: 2020
    • Botulinum toxin type A for spastic cerebral palsy: Is it time to change praxis?
      Authors: ฤŒoloviฤ‡, H., Dimitrijevic, L., Stankoviฤ‡, I., Radoviฤ‡-Janoลกeviฤ‡, D., Zlatanoviฤ‡, D.
      Citations: 1
      Year: 2020
    • The Role of Early Habilitation in Infants with Congenital Brachial Palsy
      Authors: ลฝivkoviฤ‡, V.D., Stankoviฤ‡, I., Dimitrijeviฤ‡, L., Spaleviฤ‡, M., Saviฤ‡, N.
      Citations: 1
      Year: 2018
    • The effect of physical therapy in the treatment of patients with cervical dystonia with or without concomitant use of botulinum toxin
      Authors: Stankoviฤ‡, I., ฤŒoloviฤ‡, H., ลฝivkoviฤ‡, V., ลฝivkoviฤ‡, D., Stankoviฤ‡, T.
      Citations: 2
      Year: 2018
    • Chemoinformatic investigation of antibiotic antagonism: The interference of thymus glabrescens essential oil components with the action of streptomycin
      Authors: Iliฤ‡, B.S., Miladinoviฤ‡, D.L., Kociฤ‡, B.D., ฤŒoloviฤ‡, H., Nikoliฤ‡, D.M.
      Citations: 3
      Year: 2017

 

Conclusionย 

Dr. Hristina ฤŒoloviฤ‡โ€™s profile indicates strong potential for the Robotics Integration Award. Her expertise in physical medicine and rehabilitation, combined with her research into robotic neurorehabilitation, makes her an excellent candidate for recognition. With further development in broader robotics applications and enhanced collaboration with engineers, Dr. ฤŒoloviฤ‡ could lead the way in advancing robotic integration into rehabilitation practices, positively impacting patient care across various domains.

 

 

Hilmar Bading | Neuroscience | Best Researcher Award

Prof Dr Hilmar Bading | Neuroscience | Best Researcher Awardย 

ย Professor and Head of Department at Heidelberg University, Germany

 

Professor Dr. Hilmar Bading is a distinguished neurobiologist currently serving as a Professor and Chair of the Department of Neurobiology at Heidelberg University, Germany. He is also the Director of the Interdisciplinary Center for Neurosciences (IZN) at the same institution.

professional profileย 

scopus

๐ŸŽ“ Education

Professor Bading completed his medical degree at Heidelberg University in 1984. He earned his doctorate (Dr. med.) under the supervision of Professor Wilhelm Hasselbach, with a focus on calcium transport ATPase in muscle at the Max-Planck-Institut fรผr medizinische Forschung, Heidelberg.

๐Ÿ’ผ Work Experience

Professor Bading has an extensive academic and research career. He has held key positions including Group Leader at the MRC Laboratory of Molecular Biology in Cambridge, England (1993-2001), and postdoctoral fellowships at Harvard Medical School, USA, and the Max-Planck-Institut fรผr molekulare Genetik, Berlin. Since 2001, he has led the Department of Neurobiology at Heidelberg University. Additionally, he is the scientific founder of FundaMental Pharma GmbH and the founder of the Hilmar Bading Stiftung BrainAid.

๐Ÿ”ฌ Research Focus

His research primarily revolves around the molecular mechanisms that regulate gene expression in neurons, particularly focusing on the role of nuclear calcium in neuroprotection and neurodegeneration. His groundbreaking work has significantly advanced our understanding of how synaptic activity influences gene expression in the nervous system.

๐Ÿ† Awards and Honors

Professor Bading’s contributions to science have been widely recognized. He has received several prestigious awards, including the Wolfgang-Paul-Prize from the Alexander von Humboldt-Foundation (2001), an ERC Advanced Grant (2008), and an ERC Proof-of-Concept Grant (2015). In 2019, he was elected as a member of the Leopoldina, the German National Academy of Sciences.

๐Ÿ… Memberships

He has been an active member of several prominent scientific boards and commissions, including the Scientific Advisory Board of the Spemann Graduate School of Biology and Medicine at the University of Freiburg, the Commission of the International Max-Planck Research Schools, and the Wellcome Trust Neuroscience Panel in London.

๐Ÿ‘จโ€๐Ÿซ Teaching Experience

With a commitment to nurturing the next generation of scientists, Professor Bading has supervised over 25 PhD students as the principal supervisor and co-supervised an additional 50 PhD students. His dedication to teaching is also reflected in his guidance of approximately 80 Master’s and Bachelor’s theses over the past decade.

๐Ÿ” Skills

Professor Bading’s expertise lies in molecular biology, neurobiology, and the study of intracellular signaling pathways. His leadership in academia and industry highlights his ability to translate scientific discoveries into practical applications.

publications

  • Neuronโ€“astrocyte metabolic coupling facilitates spinal plasticity and maintenance of inflammatory pain
    • Year: 2024
    • Journal: Nature Metabolism
    • Authors: Marty-Lombardi, S., Lu, S., Ambroziak, W., Fleming, T., Siemens, J.
    • Emoji: ๐Ÿง ๐Ÿ”ฌ๐Ÿ’ก
  • TwinF interface inhibitor FP802 stops loss of motor neurons and mitigates disease progression in a mouse model of ALS
    • Year: 2024
    • Journal: Cell Reports Medicine
    • Authors: Yan, J., Wang, Y.M., Hellwig, A., Bading, H.
    • Emoji: ๐Ÿฆ ๐Ÿงฌ๐Ÿ”ฌ
  • Activin A targets extrasynaptic NMDA receptors to ameliorate neuronal and behavioral deficits in a mouse model of Huntington disease
    • Year: 2023
    • Journal: Neurobiology of Disease
    • Authors: Nassrallah, W.B., Ramandi, D., Cheng, J., Bading, H., Raymond, L.A.
    • Emoji: ๐Ÿง ๐Ÿ’‰๐Ÿงฉ
  • The Disruption of NMDAR/TRPM4 Death Signaling with TwinF Interface Inhibitors: A New Pharmacological Principle for Neuroprotection
    • Year: 2023
    • Journal: Pharmaceuticals
    • Authors: Yan, J., Bading, H.
    • Emoji: ๐Ÿ’Š๐Ÿงฌ๐Ÿ”’
  • Expression of the primate-specific LINC00473 RNA in mouse neurons promotes excitability and CREB-regulated transcription
    • Year: 2023
    • Journal: Journal of Biological Chemistry
    • Authors: Pruunsild, P., Bengtson, C.P., Loss, I., Lohrer, B., Bading, H.
    • Emoji: ๐Ÿงฌ๐Ÿง ๐Ÿ“ˆ
  • Ryanodine Receptor Mediated Calcium Release Contributes to Ferroptosis Induced in Primary Hippocampal Neurons by GPX4 Inhibition
    • Year: 2023
    • Journal: Antioxidants
    • Authors: Gleitze, S., Ramรญrez, O.A., Vega-Vรกsquez, I., Paula-Lima, A., Hidalgo, C.
    • Emoji: ๐Ÿงช๐Ÿงฌ๐Ÿ’ฅ
  • Neuronal nuclear calcium signaling suppression of microglial reactivity is mediated by osteoprotegerin after traumatic brain injury
    • Year: 2022
    • Journal: Journal of Neuroinflammation
    • Authors: Frรถhlich, A., Olde Heuvel, F., Rehman, R., Bading, H., Roselli, F.
    • Emoji: ๐Ÿง โš•๏ธ๐Ÿ”ง
  • N-methyl-D-aspartate Receptor-mediated Preconditioning Mitigates Excitotoxicity in Human Induced Pluripotent Stem Cell-derived Brain Organoids
    • Year: 2022
    • Journal: Neuroscience
    • Authors: Bauersachs, H.G., Bengtson, C.P., Weiss, U., Pruunsild, P., Bading, H.
    • Emoji: ๐Ÿงช๐Ÿง ๐ŸŒฑ
  • Dysregulation of Npas4 and Inhba expression and an altered excitation-inhibition balance are associated with cognitive deficits in DBA/2 mice
    • Year: 2022
    • Journal: Learning and Memory
    • Authors: Oberlรคnder, K., Witte, V., Mallien, A.S., Bengtson, C.P., Bading, H.
    • Emoji: ๐Ÿง ๐Ÿงฉ๐Ÿ“‰
  • Disrupted expression of mitochondrial NCLX sensitizes neuroglial networks to excitotoxic stimuli and renders synaptic activity toxic
    • Year: 2022
    • Journal: Journal of Biological Chemistry
    • Authors: Hagenston, A.M., Yan, J., Bas-Orth, C., Sekler, I., Bading, H.
    • Emoji: ๐Ÿงฌโš ๏ธ๐Ÿง 

 

Athanasia Chatziefstathiou | Neuroscience | Best Researcher Award

Mrs ย Athanasia Chatziefstathiou | ย Neuroscience | Best Researcher Awardย 

PhD candidate at Aristotle University of Thessaloniki, Greece

 

Athanasia Chatziefstathiou, born on January 30, 1995, is a PhD candidate at the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki, Greece. She specializes in molecular biology, with a focus on neurodegenerative diseases, particularly the identification and functional verification of new molecular targets in blood-cerebrospinal fluid and exosomes from affected patients. Her research is driven by a passion for unraveling the molecular mechanisms underlying neurological disorders.

professional profile:

Education ๐ŸŽ“

Athanasia Chatziefstathiou is a Ph.D. candidate at the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki, Greece. Her doctoral research focuses on the “Identification and functional verification of new molecular targets of blood โ€“ cerebrospinal fluid and exosomes from patients with neurodegenerative diseases.” She holds a Masterโ€™s degree (M.Sc.) in Applied Genetics and Biodiagnosis from the same institution, which she completed in 2020. Her masterโ€™s thesis was centered on the “Optimization of protein assays for the diagnosis of neurodegenerative diseases.” Prior to that, she earned her Bachelorโ€™s degree (B.Sc.) in Biology from the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki in 2018.

Work Experience ๐Ÿ’ผ

From 2024 to 2026, Athanasia is a key member of the Greek Research Team in the IKYDA Programme, which promotes scientific cooperation between Greece and Germany. Her research within this program explores “The role of neuronal exosomes in Prion pathology.” In 2021, she served as a Research Assistant at the Faculty of Sciences, School of Biology, Aristotle University of Thessaloniki, where she contributed to the “Development of advanced biomarker technology for the differential diagnosis of Parkinson’s Disease,” a project funded by the European Union and Greek national funds. Additionally, during the same year, she worked as a Supporting Teaching Assistant at Aristotle University, aiding in the “Supporting Teaching” initiative to enhance educational activities. She also gained international experience through an ERASMUS+ Internship in Germany, where she focused on optimizing protein assays for the diagnosis of neurodegenerative diseases. In 2020, Athanasia contributed to monitoring the SARS-CoV-2 virus at the urban wastewater unit of EYATH, as a Research Assistant at Aristotle University. Her earlier experiences include internships at the Biomedical Research Foundation of the Academy of Athens (BRFAA) in 2019, where she studied pathways in Parkinson’s Disease, and at the Biomedical Sciences Research Center “Alexander Fleming” in 2018, where she used Drosophila melanogaster as a model organism for neurodegenerative diseases.

Skills & Expertise ๐Ÿง 

Athanasia has developed a strong skill set in molecular biology techniques, particularly in the context of neurodegenerative disease research. She is proficient in optimizing protein assays and advancing biomarker technology. Her data analysis skills include the use of tools such as Tableau, MySQL, Python, and R. Additionally, she has expertise in using Drosophila melanogaster as a model organism for neuroscience research.

Awards & Honors ๐Ÿ†

Her academic and research excellence has been recognized through several awards. From 2022 to 2025, she received the H.F.R.I. Scholarships for PhD Candidates, securing an Individual Fellowship for her doctoral studies. In 2023, she was honored with the 10th Hellenic Academy of Neuroimmunology award for the best research announcement.

Other Scientific Activities & Training ๐Ÿ“š

Athanasia is committed to continuous learning and professional development. In 2024, she participated in the Data Science Summer School, where she honed her skills in Tableau, MySQL, and Python for data analysis. In 2021, she completed the 2nd LAS Core Modules Course organized by BSRC โ€œAlexander Flemingโ€ in line with P.D. 56/2013. Earlier, in 2020, she completed the “Data Science R Basics” course offered by DataCamp, further expanding her expertise in data science.

Conclusion

Athanasia Chatziefstathiou is a promising researcher with a strong academic background, extensive research experience, and notable achievements in the field of neurodegenerative diseases. Her focus on molecular biology, particularly in the context of neurodegenerative diagnostics, positions her as a valuable contributor to this field. Given her achievements, dedication, and ongoing research, Athanasia is a suitable candidate for the Best Researcher Award. Her work has the potential to significantly impact our understanding of neurodegenerative diseases, making her a deserving contender for this recognition.

publication:

Carmela Conte | Neuroscience | Best Extension Activity Award

Dr Carmela Conte | Neuroscience | Best Extension Activity Award

Aggregate Professor at Department of Pharmaceutical Sciences. University of Perguia ,Italy

 

Carmela Conte is an Italian biochemist and Aggregate Professor at the University of Perugia. She holds a Masterโ€™s in Biological Sciences (1994) ๐ŸŽ“, a PhD in Medical Embryology (2000) ๐Ÿงฌ, and a specialization in Chemistry and Food Technology (2002) ๐Ÿง‘โ€๐Ÿ”ฌ. Recently, she achieved National Habilitation as an Associate Professor in Biochemistry (2023) ๐Ÿ….Since 2007, she has taught Biochemistry and Molecular Biology at the University of Perugia ๐Ÿ“š. Her research focuses on Parkinson’s disease and neuroinflammation ๐Ÿง , with notable work conducted at VUMC Medical University of Amsterdam ๐Ÿงช.Carmela is a member of the European Society for Neurochemistry and the International Parkinson and Movement Disorder Society ๐ŸŒ. She serves as a reviewer editor for Frontiers in Neuroscience and reviews for several journals ๐Ÿ“. Her contributions include numerous research papers and conference presentations ๐Ÿ—’๏ธ.She also participates in institutional committees at the University of Perugia, collaborating with scientists across Europe to advance neurodegeneration research ๐Ÿค.

 

professional profile:

scopus\

 

Education ๐ŸŽ“

Carmela Conte holds a Masterโ€™s Degree in Biological Sciences from the University of Perugia, completed on November 3, 1994. She pursued a PhD in Medical Embryology through a joint program of the Universities of Perugia and Ferrara, finishing on January 19, 2000. Additionally, she specialized in Chemistry and Food Technology at the University of Perugia from November 1, 2000, to November 1, 2002. Recently, she obtained her National Habilitation as an Associate Professor in Biochemistry, effective from September 29, 2023.

Work Experience ๐Ÿข

Since September 7, 2007, Carmela has served as an Aggregate Professor in Biochemistry at the University of Perugia, teaching courses in General and Systematic Biochemistry, Medical Applied Biochemistry, and Molecular Biology. Her dedication to teaching is complemented by her involvement in research, particularly evident during her teaching and training mobility at VUMC Medical University of Amsterdam from June 24 to July 5, 2019, where she conducted research on the role of Toll-like receptors in Parkinson’s disease.

Skills and Expertise ๐Ÿง 

Carmela’s expertise spans several critical areas, including neurodegenerative diseases, animal models of neurodegenerative diseases, signal transduction, molecular biology, and cell biology. Her research skills are deeply rooted in her comprehensive understanding of these fields, making significant contributions to the scientific community.

Awards and Honors ๐Ÿ†

Carmela has received numerous accolades for her work. She is a reviewer editor for Frontiers in Neuroscience, specifically in the section “Neurodegeneration,” and serves as an ad hoc reviewer for several prestigious journals such as Amino Acids, The Cerebellum, and Neurochemical Research. Additionally, she has been a guest editor for Molecules and Cells journals, focusing on special issues and topic collections in the field of neurodegenerative diseases.

Memberships and Networks ๐ŸŒ

An active member of the European Society for Neurochemistry since September 7, 2007, Carmela also joined the International Parkinson and Movement Disorder Society on March 17, 2022. These memberships reflect her commitment to staying connected with the broader scientific community and contributing to ongoing research and developments in her field.

Teaching Experience ๐Ÿ“š

Carmela boasts over 15 years of teaching experience at the University of Perugia, where she has imparted knowledge in General and Systematic Biochemistry, Medical Applied Biochemistry, and Molecular Biology. She also plays a pivotal role in the PhD program in Pharmaceutical Sciences as a member of the Teaching Board, showcasing her dedication to nurturing the next generation of scientists.

Research Focus ๐Ÿ”ฌ

Carmela’s research is primarily focused on neurodegenerative diseases, with particular attention to Parkinson’s disease, neuroinflammation, synucleinopathies, and oxidative stress. Her projects include studying the role of Toll-like receptors in Parkinson’s disease and investigating the effects of oxidative stress and neuroinflammation on neurodegeneration. Her work delves into the pathological mechanisms of synucleinopathies, contributing valuable insights to the field.

Scientific Contributions ๐Ÿ“

Throughout her career, Carmela has presented her research at numerous scientific meetings and conferences, including the European Society for Neurochemistry and the European Biotechnology Congress. Her notable presentations include studies on antioxidant defense mechanisms, Toll-like receptors, and vitamin D3 in neurodegenerative contexts. She has authored several influential research papers, further establishing her as a leading figure in her field.

Conclusion

Carmela Conte’s extensive education, significant research contributions, active professional memberships, and numerous collaborations make her a deserving candidate for the Best Researcher Award. Her dedication to advancing knowledge in the field of neurodegenerative diseases, coupled with her active participation in the scientific community, highlights her as a leading researcher whose work has had a profound impact on the field.

publication: